Cytel
Cytel specializes in providing statistical software and advanced analytics tailored for clinical trial design and execution. With over thirty years of experience, the company supports biotech and pharmaceutical firms in managing uncertainty and making evidence-based decisions. Cytel's offerings include industry-leading software, data-driven analytics, and strategic consulting, focusing on areas such as protocol development, regulatory support, and enrollment forecasting. By delivering real-world evidence and operational expertise, Cytel helps clients enhance efficiency and reduce costs in the life sciences development process.
Purple Squirrel Economics, Inc., founded in 2016 and based in New York City, specializes in health economics and outcomes research consulting services. The company provides a range of offerings including evidence generation, economic modeling, outcomes research, and market access strategy development. With a team of senior health economists, Purple Squirrel Economics aims to support clients in navigating the complexities of the healthcare industry by delivering strategic leadership and expertise across various therapeutic areas. In addition to its core services, the company has developed a systematic literature review tool to further assist clients in their research efforts. As of December 2020, Purple Squirrel Economics operates as a subsidiary of Cytel Inc.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at
support@teaserclub.com. Your feedback is most welcome.